Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

Market Cap	23.34B -3.8%
Revenue (ttm)	164.16B +7.0%
Net Income	2.02B -31.3%
EPS	0.39 -32.5%
Shares Out	4.99B
PE Ratio	11.96
Forward PE	13.44
Dividend	0.20 (4.22%)
Ex-Dividend Date	Jun 17, 2025

Volume	21,265,178
Open	4.740
Previous Close	4.740
Day's Range	4.630 - 4.750
52-Week Range	4.640 - 5.840
Beta	0.24
Analysts	Buy
Price Target	5.81 (+24.15%)
Earnings Date	Aug 25, 2026

About SHA:600998

Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 29,862
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600998

Financial Performance

In 2025, SHA:600998's revenue was 161.39 billion, an increase of 6.31% compared to the previous year's 151.81 billion. Earnings were 2.25 billion, a decrease of -10.07%.